Mel Walker

650 total citations
9 papers, 525 citations indexed

About

Mel Walker is a scholar working on Oncology, Orthopedics and Sports Medicine and Nephrology. According to data from OpenAlex, Mel Walker has authored 9 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Orthopedics and Sports Medicine and 2 papers in Nephrology. Recurrent topics in Mel Walker's work include Bone health and treatments (3 papers), Blood Pressure and Hypertension Studies (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Mel Walker is often cited by papers focused on Bone health and treatments (3 papers), Blood Pressure and Hypertension Studies (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Mel Walker collaborates with scholars based in United Kingdom, Switzerland and France. Mel Walker's co-authors include Andrew Lloyd, Scott Doyle, Warren Cowell, Niall Lynch, Simon Dixon, Sam Salek, Paul E. Stevens, Dónal O’Donoghue, Sean Hilton and Simon de Lusignan and has published in prestigious journals such as Nephrology Dialysis Transplantation, Lung Cancer and Clinical Therapeutics.

In The Last Decade

Mel Walker

9 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mel Walker United Kingdom 9 162 115 106 104 73 9 525
Kensuke Moriwaki Japan 10 72 0.4× 84 0.7× 85 0.8× 92 0.9× 65 0.9× 44 454
Irene Agodoa United States 18 121 0.7× 126 1.1× 259 2.4× 71 0.7× 37 0.5× 48 1.1k
Temitope Olufade United States 11 68 0.4× 98 0.9× 30 0.3× 97 0.9× 70 1.0× 24 571
Wenli Wang China 10 66 0.4× 159 1.4× 32 0.3× 26 0.3× 95 1.3× 29 552
Margaret K. Pasquale United States 15 81 0.5× 20 0.2× 89 0.8× 115 1.1× 159 2.2× 38 662
Susan Knox United Kingdom 8 115 0.7× 15 0.1× 97 0.9× 29 0.3× 86 1.2× 20 646
Jetty A. Overbeek Netherlands 14 112 0.7× 37 0.3× 54 0.5× 46 0.4× 94 1.3× 57 716
Atiqa Khalid Pakistan 7 90 0.6× 80 0.7× 14 0.1× 41 0.4× 19 0.3× 15 477
B.M.K. Donato United States 12 145 0.9× 38 0.3× 14 0.1× 74 0.7× 147 2.0× 47 660
Nigel Hague United Kingdom 14 32 0.2× 336 2.9× 40 0.4× 139 1.3× 57 0.8× 22 816

Countries citing papers authored by Mel Walker

Since Specialization
Citations

This map shows the geographic impact of Mel Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Walker more than expected).

Fields of papers citing papers by Mel Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Walker. The network helps show where Mel Walker may publish in the future.

Co-authorship network of co-authors of Mel Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Mel Walker. A scholar is included among the top collaborators of Mel Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mel Walker. Mel Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Doyle, Scott, Andrew Lloyd, & Mel Walker. (2008). Health state utility scores in advanced non-small cell lung cancer. Lung Cancer. 62(3). 374–380. 96 indexed citations
2.
Barrett‐Lee, Peter, et al.. (2007). An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting. Current Medical Research and Opinion. 23(7). 1575–1582. 16 indexed citations
3.
Walker, Mel, et al.. (2006). The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Current Medical Research and Opinion. 22(7). 1249–1256. 54 indexed citations
4.
Cramer, Joyce A., Niall Lynch, Anne-Françoise Gaudin, Mel Walker, & Warren Cowell. (2006). The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: A comparison of studies in the United States, the United Kingdom, and France. Clinical Therapeutics. 28(10). 1686–1694. 89 indexed citations
5.
Dixon, Simon, Mel Walker, & Sam Salek. (2006). Incorporating Carer Effects into Economic Evaluation. PharmacoEconomics. 24(1). 43–53. 61 indexed citations
6.
Agrawal, Samir, Neville Davidson, Mel Walker, et al.. (2006). Assessing the total costs of blood delivery to hospital oncology and haematology patients. Current Medical Research and Opinion. 22(10). 1903–1909. 24 indexed citations
7.
Lusignan, Simon de, et al.. (2005). The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrology Dialysis Transplantation. 20(10). 2089–2096. 48 indexed citations
8.
Rowe, Rachel, et al.. (2005). The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss. Current Medical Research and Opinion. 21(11). 1885–1890. 24 indexed citations
9.
Lusignan, Simon de, Tom Chan, Paul E. Stevens, et al.. (2005). Identifying patients with chronic kidney disease from general practice computer records. Family Practice. 22(3). 234–241. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026